Aging Latin American Populations Will Amplify Biotech And Biosimilar Demand
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 8 Analysts
Published
23 Jul 25
Updated
21 Aug 25
AnalystHighTarget's Fair Value
R$19.00
34.3% undervalued intrinsic discount21 Aug
R$12.48
1Y
-5.4%7D
5.5%